These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1684273)

  • 1. Ebastine in perennial allergic rhinitis.
    Picado Vallés C; Cadahia García A; Cisteró Bahima A; Cano Cantudo L; Sanz Amaro A; Zayas Sanza JM
    Ann Allergy; 1991 Dec; 67(6):615-8. PubMed ID: 1684273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis.
    Murris-Espin M; Melac M; Charpentier JC; Didier A
    Ann Allergy Asthma Immunol; 1998 May; 80(5):399-403. PubMed ID: 9609610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
    Sastre J
    Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of the efficacy and tolerability of azelastine nasal spray versus ebastine tablets in patients with seasonal allergic rhinitis].
    Antépara I; Jaúregui I; Basomba A; Cadahia A; Feo F; García JJ; Gonzalo MA; Luna I; Rubio M; Vázquez M
    Allergol Immunopathol (Madr); 1998; 26(1):9-16. PubMed ID: 9585822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults.
    Gehanno P; Bremard-Oury C; Zeisser P
    Ann Allergy Asthma Immunol; 1996 Jun; 76(6):507-12. PubMed ID: 8673684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative clinical studies with ebastine: efficacy and tolerability.
    Luria X
    Drug Saf; 1999; 21 Suppl 1():63-7; discussion 81-7. PubMed ID: 10597869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study.
    Guadaño EM; Serra-Batlles J; Meseguer J; Castillo JA; De Molina M; Valero A; Picado C;
    Allergy; 2004 Jul; 59(7):766-71. PubMed ID: 15180765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Ratner P; Hampel F; Van Bavel J; Howland W
    Int Arch Allergy Immunol; 2004 Apr; 133(4):371-9. PubMed ID: 15031611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ebastine (kestine 20) in therapy of allergic rhinitis].
    Petrovskaia TIu; Sergeeva TA; Lopatin AS
    Vestn Otorinolaringol; 2007; (3):51-3. PubMed ID: 17768822
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antihistaminics. Side effects also after raising dosage at the placebo level].
    MMW Fortschr Med; 2003 May; 145(22):50-1. PubMed ID: 12866280
    [No Abstract]   [Full Text] [Related]  

  • 11. [In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
    MMW Fortschr Med; 2003 May; 145(22):51. PubMed ID: 12866281
    [No Abstract]   [Full Text] [Related]  

  • 12. A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Multicentre Study Group.
    Bousquet J; Gaudaño EM; Palma Carlos AG; Staudinger H
    Allergy; 1999 Jun; 54(6):562-8. PubMed ID: 10435469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ebastine vs terfenadine in allergic rhinitis].
    Terán Ortíz L; Flores Sandoval G; Orea Solano M; Camarena A
    Rev Alerg; 1993; 40(4):82-5. PubMed ID: 7908244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ebastine : treatment of perennial rhinitis in the child].
    Benavente V; Eseverri JL; Botey J; Marin A
    Allerg Immunol (Paris); 1996 Oct; 28(8):277-81. PubMed ID: 9011166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebastine increases IFN-gamma production in patients with persistent allergic rhinitis.
    Ciprandi G; Cirillo I; Pistorio A; Di Gioacchino M; Fenoglio D
    J Biol Regul Homeost Agents; 2009; 23(1):31-6. PubMed ID: 19321044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the skin reaction to histamine by ebastine.
    Nelson HS; Bucher B; Buchmeier A; Oppenheimer J; Garcia J
    Ann Allergy Asthma Immunol; 1995 May; 74(5):442-7. PubMed ID: 7749977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.
    Wiseman LR; Faulds D
    Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consistency of the efficacy of cetirizine and ebastine on skin reactivity.
    Frossard N; Melac M; Benabdesselam O; Pauli G
    Ann Allergy Asthma Immunol; 1998 Jan; 80(1):61-5. PubMed ID: 9475569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihistamines in severe/chronic rhinitis.
    Bousquet J
    Clin Exp Allergy; 1998 Dec; 28 Suppl 6():49-53. PubMed ID: 9988436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical studies of the efficacy and tolerability of ebastine 10 or 20 mg once daily in the treatment of seasonal allergic rhinitis in the US.
    Storms WW
    Drugs; 1996; 52 Suppl 1():20-5. PubMed ID: 8828022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.